| Rodrigo Mendes, | |
|
2 Trap Falls Road, Suite 414, Shelton, CT 06484 | |
| (203) 929-7353 | |
| (203) 929-9190 |
| Full Name | Rodrigo Mendes |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 16 Years |
| Location | 2 Trap Falls Road, Shelton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881848117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 071769 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midstate Medical Center | Meriden, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Anesthesia Associates Llc | 1759281165 | 373 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center.
Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research contract from the National Cancer Institute.
› Verified 2 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center.
Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research contract from the National Cancer Institute.
› Verified 2 days ago
| Entity Name | Stamford Anesthesiology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376608448 PECOS PAC ID: 9335191667 Enrollment ID: O20050215000851 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center.
Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research contract from the National Cancer Institute.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rodrigo Mendes, 2 Trap Falls Road, Suite 414, Shelton, CT 06484-7623 Ph: (203) 929-7353 | Rodrigo Mendes, 2 Trap Falls Road, Suite 414, Shelton, CT 06484 Ph: (203) 929-7353 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center.
Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research contract from the National Cancer Institute.
› Verified 2 days ago
Natalie Berardesca, GRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Road, Suite 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
Gloria Bienkowski, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4 Armstrong Rd, Shelton, CT 06484 Phone: 203-929-7353 | |
Lisa Ramondetta, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Corporate Dr Fl 9, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
Michelle M Campbell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Road, Suite 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
John Negugogor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd Ste 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
Bradley Hamilton, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd, Suite 414, Shelton, CT 06484 Phone: 860-282-4133 Fax: 860-289-0746 | |
Caroline Ferrara, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd Ste 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 |